FBRX
Forte Biosciences Inc (FBRX)
Healthcare • NASDAQ • $24.02-8.22%
Key Fundamentals
- Symbol
- FBRX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $24.02
- Daily Change
- -8.22%
- Market Cap
- $491.90M
- Trailing P/E
- N/A
- Forward P/E
- -5.75
- 52W High
- $35.80
- 52W Low
- $6.20
- Analyst Target
- $63.75
- Dividend Yield
- N/A
- Beta
- 3.00
About Forte Biosciences Inc
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Company websiteResearch FBRX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.